These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery]. Varela Crespo CA, Sanabria Carretero P, Palomero Rodríguez MA, Tormo las de Heras C, Rodríguez Pérez E, Goldman Tarlousky L. Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653 [Abstract] [Full Text] [Related]
43. [Dental extraction in patients with bleeding disorders. Proposal of a protocol based on the type of anesthesia used]. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaërt M, Mercier J. Rev Stomatol Chir Maxillofac; 2003 Apr; 104(2):73-6. PubMed ID: 12750623 [Abstract] [Full Text] [Related]
44. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P. Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313 [Abstract] [Full Text] [Related]
45. Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital. Hewson I, Makhmalbaf P, Street A, McCarthy P, Walsh M. Haemophilia; 2011 Jan; 17(1):e185-8. PubMed ID: 20557354 [Abstract] [Full Text] [Related]
46. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A. Spine (Phila Pa 1976); 2008 Nov 15; 33(24):2577-80. PubMed ID: 19011538 [Abstract] [Full Text] [Related]
49. What influence do anticoagulants have on oral implant therapy? A systematic review. Madrid C, Sanz M. Clin Oral Implants Res; 2009 Sep 15; 20 Suppl 4():96-106. PubMed ID: 19663955 [Abstract] [Full Text] [Related]
50. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin]. Ait Houssa M, Selkane C, Amahzoune B, El Bekkali Y, Wahid FA, Moutaki Allah Y, Boulahya A, Ibat D, Drissi M, Azendour H, Elkirat A. Ann Cardiol Angeiol (Paris); 2007 Dec 15; 56(6):308-12. PubMed ID: 17976511 [Abstract] [Full Text] [Related]
54. Bleeding disorders: characterization, dental considerations and management. Israels S, Schwetz N, Boyar R, McNicol A. J Can Dent Assoc; 2006 Nov 15; 72(9):827. PubMed ID: 17109803 [Abstract] [Full Text] [Related]
55. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. An alternative method to discontinuing anticoagulant therapy. Borea G, Montebugnoli L, Capuzzi P, Magelli C. Oral Surg Oral Med Oral Pathol; 1993 Jan 15; 75(1):29-31. PubMed ID: 8419869 [Abstract] [Full Text] [Related]
56. Clinical use of synthetic antifibrinolytic agents during liver transplantation. Kang Y. Semin Thromb Hemost; 1993 Jan 15; 19(3):258-61. PubMed ID: 8362255 [No Abstract] [Full Text] [Related]
58. Effect of topical tranexamic acid in open heart surgery. Abul-Azm A, Abdullah KM. Eur J Anaesthesiol; 2006 May 15; 23(5):380-4. PubMed ID: 16438759 [Abstract] [Full Text] [Related]